Bruker (BRKR) Net Income Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Bruker | 8.89 Bn | 8.77 Bn | 379.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -19.62% |
| Dec 31, 2025 | -38.10% |
| Sep 30, 2025 | -24.93% |
| Jun 30, 2025 | -31.69% |
| Mar 31, 2025 | 9.12% |
| Dec 31, 2024 | -25.87% |
| Sep 30, 2024 | -8.02% |
| Jun 30, 2024 | -26.75% |
| Mar 31, 2024 | 11.03% |
| Dec 31, 2023 | 13.71% |
| Sep 30, 2023 | 14.87% |
| Jun 30, 2023 | 12.83% |
| Mar 31, 2023 | 22.86% |
| Dec 31, 2022 | 24.15% |
| Sep 30, 2022 | 18.57% |
| Jun 30, 2022 | 15.67% |
| Mar 31, 2022 | 23.40% |
| Dec 31, 2021 | 21.51% |
| Sep 30, 2021 | 13.39% |
| Jun 30, 2021 | 31.73% |
| Mar 31, 2021 | 19.62% |
| Dec 31, 2020 | 37.84% |
| Sep 30, 2020 | 33.79% |
| Jun 30, 2020 | 0.93% |
| Mar 31, 2020 | 8.97% |
| Dec 31, 2019 | 30.61% |
| Sep 30, 2019 | 57.73% |
| Jun 30, 2019 | 17.11% |
| Mar 31, 2019 | 25.15% |
| Dec 31, 2018 | 16.59% |
| Sep 30, 2018 | 21.20% |
| Jun 30, 2018 | 6.22% |
| Mar 31, 2018 | 36.89% |
| Dec 31, 2017 | 23.29% |
| Sep 30, 2017 | -1.18% |
| Jun 30, 2017 | 19.38% |
| Mar 31, 2017 | 7.52% |
| Dec 31, 2016 | -11.87% |
| Sep 30, 2016 | 18.52% |
| Jun 30, 2016 | -8.12% |
| Mar 31, 2016 | 15.07% |
| Dec 31, 2015 | 23.65% |
| Sep 30, 2015 | -14.30% |
| Jun 30, 2015 | 0.17% |
| Mar 31, 2015 | -15.48% |